Cargando…

Diagnosis and Treatment of Acute Pleural Effusion following Radioiodine Remnant Ablation Post Lobectomy for Thyroid Cancer

Radioiodine remnant ablation (RRA) was previously demonstrated to be a safe and effective alternative to completion thyroidectomy for patients with differentiated thyroid cancer (DTC). However, its side effects have not been fully investigated, particularly in patients with lobectomy. We reported a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Xian, Wang, Pengwen, Sa, Ri, Cheng, Lin, Jin, Yuchen, Song, Hongjun, Chen, Libo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777309/ https://www.ncbi.nlm.nih.gov/pubmed/36552989 http://dx.doi.org/10.3390/diagnostics12122982

Ejemplares similares

Initial or salvage treatment with apatinib shows promise against radioiodine-refractory differentiated thyroid carcinoma
por: Qiu, Xian, et al.
Publicado: (2022)

Assessment of Different Radioiodine Doses for Post-ablation Therapy of Thyroid Remnants: A Systematic Review
por: Ansari, Mojtaba, et al.
Publicado: (2022)

Radioiodine Remnant Ablation: A Critical Review
por: Bal, Chandra Sekhar, et al.
Publicado: (2015)

Scintigraphic evaluation of salivary gland function in thyroid cancer patients after radioiodine remnant ablation
por: Krčálová, Eva, et al.
Publicado: (2020)

Radioiodine remnant ablation in stage I adult papillary thyroid carcinoma: does it improve postoperative outcome?
por: Hay, Ian D, et al.
Publicado: (2022)

Assessment of three different radioiodine doses for ablation therapy of thyroid remnants: Efficiency, complications and patient comfort
por: Soyluoglu, Selin, et al.
Publicado: (2023)

SAT525 Long-Term Outcomes in Stage I Thyroid Cancer Without Radioiodine Remnant Ablation
por: Mubeen, Faiza, et al.
Publicado: (2023)

Distinguishing Patients With Distant Metastatic Differentiated Thyroid Cancer Who Biochemically Benefit From Next Radioiodine Treatment
por: Sa, Ri, et al.
Publicado: (2020)

Clinical Outcome of Remnant Thyroid Ablation with Low Dose Radioiodine in Korean Patients with Low to Intermediate-risk Thyroid Cancer
por: Ha, Seunggyun, et al.
Publicado: (2015)

Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
por: Pitoia, Fabián, et al.
Publicado: (2012)

Graves’ disease diagnosed in remnant thyroid after lobectomy for thyroid cancer
por: Jin, Meihua, et al.
Publicado: (2022)

Targeting IGF2BP2 Promotes Differentiation of Radioiodine Refractory Papillary Thyroid Cancer via Destabilizing RUNX2 mRNA
por: Sa, Ri, et al.
Publicado: (2022)

Regional Variation across Canadian Centers in Radioiodine Administration for Thyroid Remnant Ablation in Well-Differentiated Thyroid Cancer Diagnosed in 2000–2010
por: Rachinsky, I., et al.
Publicado: (2016)

Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer
por: Lv, Rong-Bin, et al.
Publicado: (2017)

Radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids - early effect
por: Makarewicz, Jacek, et al.
Publicado: (2010)

Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment
por: Bal, Chandrasekhar, et al.
Publicado: (2015)

A pre-ablative thyroid-stimulating hormone with 30–70 mIU/L achieves better response to initial radioiodine remnant ablation in differentiated thyroid carcinoma patients
por: Xiao, Juan, et al.
Publicado: (2021)

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi
por: Kukulska, Aleksandra, et al.
Publicado: (2010)

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer – a prospective comparison of long-term outcomes
por: Kukulska, Aleksandra, et al.
Publicado: (2020)

Radioiodine Thyroid Ablation in Graves’ Hyperthyroidism: Merits and Pitfalls
por: Nwatsock, J. F., et al.
Publicado: (2012)

The Effectiveness of Recombinant Human Thyroid-Stimulating Hormone versus Thyroid Hormone Withdrawal Prior to Radioiodine Remnant Ablation in Thyroid Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Pak, Kyoungjune, et al.
Publicado: (2014)

Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis
por: Ahn, Jonghwa, et al.
Publicado: (2020)

Strong Neck Accumulation of (131)I Is a Predictor of Incomplete Low-Dose Radioiodine Remnant Ablation Using Recombinant Human Thyroid-Stimulating Hormone
por: Enomoto, Keisuke, et al.
Publicado: (2015)

Myopathy following postoperative ablative radioiodine for follicular carcinoma of the thyroid
por: Price, Hermione C, et al.
Publicado: (2009)

Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report
por: Jin, Yuchen, et al.
Publicado: (2017)

ERBB2 as a prognostic biomarker correlates with immune infiltrates in papillary thyroid cancer
por: Jin, Yuchen, et al.
Publicado: (2022)

Anaplastic thyroid carcinoma presenting as bilateral pleural effusion
por: Sodhi, R., et al.
Publicado: (2014)

Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer
por: Biondi, Bernadette, et al.
Publicado: (2009)

Pleural Effusions: Their Diagnosis and Treatment
por: Sheen, Alfred
Publicado: (1893)

TSH ≥30 mU/L may not be necessary for successful (131)I remnant ablation in patients with differentiated thyroid cancer
por: Ju, Nianting, et al.
Publicado: (2023)

The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
por: Kim, Hee Kyung, et al.
Publicado: (2020)

Pleural Effusion
por: Gray, Frank D.
Publicado: (1963)

Pleural Effusion
por: Brunton, T. Lauder
Publicado: (1898)

Pleural Effusion
por: Sherding, Robert G., et al.
Publicado: (2006)

Pleural Effusions
Publicado: (1877)

Role of pleural biopsy in etiological diagnosis of pleural effusion
por: Pandit, Sudipta, et al.
Publicado: (2010)

Heath-related quality of life in thyroid cancer patients following radioiodine ablation
por: Taïeb, David, et al.
Publicado: (2011)

Efficacy and safety of radiofrequency ablation for benign thyroid nodules in patients with previous thyroid lobectomy
por: Yan, Lin, et al.
Publicado: (2021)

Endoscopic thyroid lobectomy vs Conventional open thyroid lobectomy
por: Imran, Mariam, et al.
Publicado: (2020)

Epithelioid sarcoma with spontaneous pneumothorax and massive pleural effusion
por: Jeon, So-Yeon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ag8t5j8gubd1j2jqjg5r2b4n7p